MTOR and cancer: In cancer particularly, the P13K-AKT-mTOR pathway is often dysregulated and abnormally activated in human cancers in several mechanisms involving receptor tyrosine kinases (RTKs), Akt/PKB, tensin homolog (PTEN), MTOR, and other oncogene suppressor genes [69,70,71,72].